318 related articles for article (PubMed ID: 27481130)
1. Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis.
Verstovsek S; Manshouri T; Pilling D; Bueso-Ramos CE; Newberry KJ; Prijic S; Knez L; Bozinovic K; Harris DM; Spaeth EL; Post SM; Multani AS; Rampal RK; Ahn J; Levine RL; Creighton CJ; Kantarjian HM; Estrov Z
J Exp Med; 2016 Aug; 213(9):1723-40. PubMed ID: 27481130
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
Ozono Y; Shide K; Kameda T; Kamiunten A; Tahira Y; Sekine M; Akizuki K; Nakamura K; Iwakiri H; Sueta M; Hidaka T; Kubuki Y; Yamamoto S; Hasuike S; Sawaguchi A; Nagata K; Shimoda K
Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
[TBL] [Abstract][Full Text] [Related]
3. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
[TBL] [Abstract][Full Text] [Related]
4. GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes.
Manshouri T; Veletic I; Li P; Yin CC; Post SM; Verstovsek S; Estrov Z
Cell Death Dis; 2022 May; 13(5):481. PubMed ID: 35595725
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice.
Saito N; Yamauchi T; Kawano N; Ono R; Yoshida S; Miyamoto T; Kamimura T; Shultz LD; Saito Y; Takenaka K; Shimoda K; Harada M; Akashi K; Ishikawa F
Int J Hematol; 2022 Feb; 115(2):198-207. PubMed ID: 34773575
[TBL] [Abstract][Full Text] [Related]
6. The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
Uchiyama T; Kawabata H; Miura Y; Yoshioka S; Iwasa M; Yao H; Sakamoto S; Fujimoto M; Haga H; Kadowaki N; Maekawa T; Takaori-Kondo A
Cancer Med; 2015 Oct; 4(10):1558-72. PubMed ID: 26276681
[TBL] [Abstract][Full Text] [Related]
7. [The role of fibrocytes in myelofibrosis and fibrocyte regulation as a novel treatment approach].
Maekawa T; Kato S; Kimura F
Rinsho Ketsueki; 2020; 61(1):3-10. PubMed ID: 32023599
[TBL] [Abstract][Full Text] [Related]
8. Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
Leukemia; 2017 Dec; 31(12):2709-2716. PubMed ID: 28386106
[TBL] [Abstract][Full Text] [Related]
9. FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation.
Crawford JR; Pilling D; Gomer RH
J Leukoc Biol; 2012 Oct; 92(4):699-711. PubMed ID: 22493081
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis.
Madala SK; Edukulla R; Schmidt S; Davidson C; Ikegami M; Hardie WD
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):777-86. PubMed ID: 24199692
[TBL] [Abstract][Full Text] [Related]
11. IL-4 and serum amyloid P inversely regulate fibrocyte differentiation by targeting store-operated Ca
Zhong JN; Lan L; Chen YF; Huang G; He GZ; Yang J; Gao YD
Pharmacol Rep; 2018 Feb; 70(1):22-28. PubMed ID: 29306759
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of human fibrocytes derived from monocytes reveals their profibrotic phenotype through paracrine effects.
Abe S; Sato S; Aono Y; Azuma M; Kishi M; Koyama K; Takahashi N; Kagawa K; Kawano H; Nishioka Y
J Med Invest; 2020; 67(1.2):102-112. PubMed ID: 32378592
[TBL] [Abstract][Full Text] [Related]
13. The Development of Serum Amyloid P as a Possible Therapeutic.
Pilling D; Gomer RH
Front Immunol; 2018; 9():2328. PubMed ID: 30459752
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
[TBL] [Abstract][Full Text] [Related]
15. Focus on Osteosclerotic Progression in Primary Myelofibrosis.
Spampinato M; Giallongo C; Romano A; Longhitano L; La Spina E; Avola R; Scandura G; Dulcamare I; Bramanti V; Di Rosa M; Vicario N; Parenti R; Li Volti G; Tibullo D; Palumbo GA
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477816
[TBL] [Abstract][Full Text] [Related]
16. Improved serum-free culture conditions for spleen-derived murine fibrocytes.
Crawford JR; Pilling D; Gomer RH
J Immunol Methods; 2010 Dec; 363(1):9-20. PubMed ID: 20888336
[TBL] [Abstract][Full Text] [Related]
17. The long pentraxin PTX3 promotes fibrocyte differentiation.
Pilling D; Cox N; Vakil V; Verbeek JS; Gomer RH
PLoS One; 2015; 10(3):e0119709. PubMed ID: 25774777
[TBL] [Abstract][Full Text] [Related]
18. First identification of resident and circulating fibrocytes in Dupuytren's disease shown to be inhibited by serum amyloid P and Xiapex.
Iqbal SA; Hayton MJ; Watson JS; Szczypa P; Bayat A
PLoS One; 2014; 9(6):e99967. PubMed ID: 24933153
[TBL] [Abstract][Full Text] [Related]
19. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fibrocyte differentiation by serum amyloid P.
Pilling D; Buckley CD; Salmon M; Gomer RH
J Immunol; 2003 Nov; 171(10):5537-46. PubMed ID: 14607961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
